Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
Clinical trial NCT05734053 · COMPLETED
Trial details
- NCT number
- NCT05734053
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-06-28
- Primary completion
- 2022-09-08
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.